Immunocore
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $115,927 | $106,677 | $77,427 | $103,693 |
Gross Profit | 114,839 | 106,243 | 74,806 | 103,180 |
EBITDA | 3,574 | 16,528 | -8,033 | 4,145 |
EBIT | 2,548 | 15,581 | -8,651 | 3,347 |
Net Income | -808 | 12,971 | -22,277 | 785 |
Net Change In Cash | 115,927 | 106,677 | 77,427 | 103,693 |
Free Cash Flow | -6,264 | -15,529 | -35,535 | -5,204 |
Cash | 484,920 | 452,675 | 467,709 | 498,413 |
Basic Shares | 50,973 | 52,934 | 50,345 | 50,403 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $297,569 | $247,983 | $197,385 | $144,234 |
Gross Profit | 291,355 | 242,439 | 196,565 | 138,940 |
EBITDA | 387 | -38,504 | -40,870 | -38,354 |
EBIT | -2,042 | -41,861 | -44,106 | -42,768 |
Net Income | -26,418 | -40,805 | -43,751 | -43,464 |
Net Change In Cash | 297,569 | 247,983 | 197,385 | 144,234 |
Free Cash Flow | -11,197 | 20,888 | -1,966 | -51,412 |
Cash | 467,709 | 455,731 | 442,626 | 402,472 |
Basic Shares | 50,345 | 49,991 | 48,888 | 45,714 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.02 |
2026-03-31 | $0.25 |
2025-12-31 | -$0.60 |
2025-09-30 | -$0.003 |